198 related articles for article (PubMed ID: 29807104)
1. Dapagliflozin improves blood glucose in diabetes on triple oral hypoglycemic agents having inadequate glucose control.
Jeon HJ; Ku EJ; Oh TK
Diabetes Res Clin Pract; 2018 Aug; 142():188-194. PubMed ID: 29807104
[TBL] [Abstract][Full Text] [Related]
2. Effect of Dapagliflozin on Glycemic Variability in Patients with Type 2 Diabetes under Insulin Glargine Combined with Other Oral Hypoglycemic Drugs.
Luo M; Kong X; Wang H; Zhai X; Cai T; Ding B; Hu Y; Jing T; Su X; Li H; Ma J
J Diabetes Res; 2020; 2020():6666403. PubMed ID: 33299890
[TBL] [Abstract][Full Text] [Related]
3. Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study.
Kostev K; Pscherer S; Rist R; Busch S; Scheerer MF
J Diabetes Sci Technol; 2017 May; 11(3):590-596. PubMed ID: 28300454
[TBL] [Abstract][Full Text] [Related]
4. Comparison betweeen dapagliflozin add-on therapy and insulin dose escalation in patients with uncontrolled type 2 diabetes treated with insulin: DVI study.
Shin Y; Choi H; Lim S
Diabetes Res Clin Pract; 2021 May; 175():108843. PubMed ID: 33933498
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of dapagliflozin in addition to insulin therapy in Japanese patients with type 2 diabetes: Results of the interim analysis of 16-week double-blind treatment period.
Araki E; Onishi Y; Asano M; Kim H; Ekholm E; Johnsson E; Yajima T
J Diabetes Investig; 2016 Jul; 7(4):555-64. PubMed ID: 27181422
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.
Wilding JP; Woo V; Rohwedder K; Sugg J; Parikh S;
Diabetes Obes Metab; 2014 Feb; 16(2):124-36. PubMed ID: 23911013
[TBL] [Abstract][Full Text] [Related]
7. [Short-term intensive combined therapy with metformin, sagliptin and dapagliflozin for newly diagnosed type 2 diabetes: efficacy, weight control and safety].
Xu Y; Wu P; Wen W; Chen H
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Nov; 39(11):1305-1311. PubMed ID: 31852646
[TBL] [Abstract][Full Text] [Related]
8. Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.
Henry RR; Strange P; Zhou R; Pettus J; Shi L; Zhuplatov SB; Mansfield T; Klein D; Katz A
Diabetes Technol Ther; 2018 Nov; 20(11):715-724. PubMed ID: 30222367
[TBL] [Abstract][Full Text] [Related]
9. [Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin].
Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S27-38. PubMed ID: 23529568
[TBL] [Abstract][Full Text] [Related]
10. Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice.
Omori K; Nakamura A; Miyoshi H; Takahashi K; Kitao N; Nomoto H; Kameda H; Cho KY; Takagi R; Hatanaka KC; Terauchi Y; Atsumi T
Metabolism; 2019 Sep; 98():27-36. PubMed ID: 31202833
[TBL] [Abstract][Full Text] [Related]
11. Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.
McInnes N; Hall S; Sultan F; Aronson R; Hramiak I; Harris S; Sigal RJ; Woo V; Liu YY; Gerstein HC
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32403130
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Dapagliflozin Effectiveness as Add-on Therapy for the Treatment of Type 2 Diabetes Mellitus in a Qatari Population.
Al AdAwi RM; Jassim Z; Elgaily D; Abdelaziz H; Sree B; Mohamed Ibrahim MI
Sci Rep; 2019 May; 9(1):6864. PubMed ID: 31053747
[TBL] [Abstract][Full Text] [Related]
13. The SGLT2 Inhibitor Dapagliflozin Significantly Improves the Peripheral Microvascular Endothelial Function in Patients with Uncontrolled Type 2 Diabetes Mellitus.
Sugiyama S; Jinnouchi H; Kurinami N; Hieshima K; Yoshida A; Jinnouchi K; Nishimura H; Suzuki T; Miyamoto F; Kajiwara K; Jinnouchi T
Intern Med; 2018 Aug; 57(15):2147-2156. PubMed ID: 29607968
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study.
Shigiyama F; Kumashiro N; Miyagi M; Ikehara K; Kanda E; Uchino H; Hirose T
Cardiovasc Diabetol; 2017 Jul; 16(1):84. PubMed ID: 28683796
[TBL] [Abstract][Full Text] [Related]
15. Saxagliptin/dapagliflozin is non-inferior to insulin glargine in terms of β-cell function in subjects with latent autoimmune diabetes in adults: A 12-month, randomized, comparator-controlled pilot study.
Maddaloni E; Naciu AM; Mignogna C; Galiero R; Amendolara R; Fogolari M; Satta C; Serafini C; Angeletti S; Cavallo MG; Cossu E; Sasso FC; Buzzetti R; Pozzilli P;
Diabetes Obes Metab; 2024 May; 26(5):1670-1677. PubMed ID: 38297915
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial.
Mathieu C; Dandona P; Gillard P; Senior P; Hasslacher C; Araki E; Lind M; Bain SC; Jabbour S; Arya N; Hansen L; Thorén F; Langkilde AM;
Diabetes Care; 2018 Sep; 41(9):1938-1946. PubMed ID: 30026335
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of dapagliflozin plus saxagliptin versus insulin glargine over 52 weeks as add-on to metformin with or without sulphonylurea in patients with type 2 diabetes: A randomized, parallel-design, open-label, Phase 3 trial.
Vilsbøll T; Ekholm E; Johnsson E; Garcia-Sanchez R; Dronamraju N; Jabbour SA; Lind M
Diabetes Obes Metab; 2020 Jun; 22(6):957-968. PubMed ID: 32003150
[TBL] [Abstract][Full Text] [Related]
18. Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study).
Rosenstock J; Hollander P; Bhargava A; Ilag LL; Pollom RK; Zielonka JS; Huster WJ; Prince MJ
Diabetes Obes Metab; 2015 Aug; 17(8):734-41. PubMed ID: 25931141
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of dapagliflozin in patients with type 2 diabetes mellitus receiving high doses of insulin: a randomized trial.
Wilding JP; Woo V; Soler NG; Pahor A; Sugg J; Rohwedder K; Parikh S;
Ann Intern Med; 2012 Mar; 156(6):405-15. PubMed ID: 22431673
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study.
Dandona P; Mathieu C; Phillip M; Hansen L; Tschöpe D; Thorén F; Xu J; Langkilde AM;
Diabetes Care; 2018 Dec; 41(12):2552-2559. PubMed ID: 30352894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
